Jane Liang White
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology top 10%
- Pharmacology top 2%
- Plant Science top 10%
- Co-authors
- Mervyn J. BibbMaria Rita MigliorinoKi Hyeong LeeEric SbarSeiji NihoTony MokRafael RosellAdam Płużański
- Topics
- Microbial Natural Products and Biosynthesis (7 papers)CAR-T cell therapy research (4 papers)Genomics and Phylogenetic Studies (4 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Jane Liang White
22 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 1.1k
- Molecular Biology 982
- Pharmacology 487
- Plant Science 239
Countries citing papers authored by Jane Liang White
This map shows the geographic impact of Jane Liang White's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Liang White with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Liang White more than expected).
Fields of papers citing papers by Jane Liang White
This network shows the impact of papers produced by Jane Liang White. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Liang White. The network helps show where Jane Liang White may publish in the future.
Co-authorship network of co-authors of Jane Liang White
This figure shows the co-authorship network connecting the top 25 collaborators of Jane Liang White. A scholar is included among the top collaborators of Jane Liang White based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Liang White. Jane Liang White is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 1 | |
| 3 | 12 | |
| 4 | 224 | |
| 5 | Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer and EGFR-Activating Mutationsbreakdown → | 331 |
| 6 | 5 | |
| 7 | 2 | |
| 8 | Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trialbreakdown → | 854 |
| 9 | 104 | |
| 10 | 30 | |
| 11 | 42 | |
| 12 | Application of redD, the transcriptional activator gene of the undecylprodigiosin biosynthetic pathway, as a reporter for transcriptional activity in Streptomyces coelicolor A3(2) and Streptomyces lividans. | 42 |
| 13 | 49 | |
| 14 | 118 | |
| 15 | 38 | |
| 16 | 21 | |
| 17 | 177 | |
| 18 | 50 | |
| 19 | Nopaline Ti-plasmid, pTiT37, T-DNA insertions into a flax genome. | 36 |
| 20 | The role of cytosine methylation in the control of nopaline synthase gene expression in a plant tumor. | 120 |
About Jane Liang White
Jane Liang White is a scholar working on Microbiology, Pharmacology and Oncology, having authored 22 papers that have together received 2.3k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (7 papers), CAR-T cell therapy research (4 papers) and Genomics and Phylogenetic Studies (4 papers). The work is most often cited by research in Oncology (1.1k citations), Pulmonary and Respiratory Medicine (1.1k citations) and Pharmacology (487 citations). Jane Liang White has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Mervyn J. Bibb, Maria Rita Migliorino, Ki Hyeong Lee, Eric Sbar, Seiji Niho, Tony Mok, Rafael Rosell, Adam Płużański, Yi‐Long Wu and Tao Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.